Tien Liang BioTech Co., Ltd. (TPEX:4127)

Taiwan · Delayed Price · Currency is TWD

70.60

-2.90 (-3.95%)

Jul 30, 2026, 1:01 PM CST

Tien Liang BioTech Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	593.46	511.79	385.21	459.99	528.52	571.32
Revenue Growth	54.57%	32.86%	-16.26%	-12.97%	-7.49%	32.53%
Gross Profit	337.32	287.94	229.91	286.15	336.55	338.28
Operating Income	-6.7	-16.14	0.59	18.87	58.29	42.95
Net Income	6.35	-10.25	11.7	17.73	59.48	46.61
Earnings Per Share	0.14	-0.22	0.26	0.39	1.30	1.02
EPS Growth	-70.84%	-	-34.04%	-70.19%	27.63%	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	170.93	152.31	130.67	142.22	107.84	118.47
Total Debt	598	598	335.38	70.88	101.4	132.67
Net Cash (Debt)	-427.07	-445.69	-204.71	71.34	6.44	-14.21
Net Cash Growth	-	-	-	1007.04%	-	-
Net Cash Per Share	-9.33	-9.74	-4.47	1.56	0.14	-0.31

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	15.97	19.23	48.66	69.67	21.88	45.21
Capital Expenditures	-32.11	-23.19	-4.05	-4.96	-1.01	-0.6
Free Cash Flow	-16.14	-3.96	44.61	64.71	20.87	44.61
Free Cash Flow Growth	-	-	-31.05%	210.05%	-53.22%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	56.84%	56.26%	59.69%	62.21%	63.68%	59.21%
Operating Margin	-1.13%	-3.15%	0.15%	4.10%	11.03%	7.52%
Pretax Margin	0.96%	-2.30%	3.40%	4.00%	11.23%	8.54%
Profit Margin	1.07%	-2.00%	3.04%	3.85%	11.25%	8.16%
FCF Margin	-2.72%	-0.77%	11.58%	14.07%	3.95%	7.81%

Dividends

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Dividend Per Share	0.500
Dividend Per Share Growth	-
Dividend Yield	3.50%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	530.08	-	162.37	37.42	11.89	14.53
Forward PE	-	10.79	10.79	10.79	10.79	10.79
P/FCF Ratio	-	-	42.57	10.25	33.88	15.18
PS Ratio	5.67	2.77	4.93	1.44	1.34	1.19